Medifast (NYSE:MED) Announces Earnings Results

Medifast (NYSE:MED - Get Free Report) posted its earnings results on Tuesday. The specialty retailer reported $0.10 EPS for the quarter, beating the consensus estimate of ($0.16) by $0.26, Zacks reports. The firm had revenue of $119.00 million for the quarter, compared to analyst estimates of $114.25 million. Medifast had a return on equity of 10.64% and a net margin of 0.35%. Medifast updated its Q1 2025 guidance to -0.500-0.000 EPS.

Medifast Price Performance

Shares of Medifast stock traded up $0.38 during trading hours on Friday, hitting $14.71. The company had a trading volume of 329,782 shares, compared to its average volume of 232,291. The company's 50-day moving average is $16.25 and its two-hundred day moving average is $17.97. The company has a market cap of $160.96 million, a P/E ratio of 81.74 and a beta of 1.14. Medifast has a twelve month low of $13.57 and a twelve month high of $42.68.

Analysts Set New Price Targets

Separately, DA Davidson dropped their price objective on Medifast from $17.00 to $16.50 and set a "neutral" rating on the stock in a report on Wednesday.

About Medifast

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.